Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study

European Journal of Heart Failure

Volumn 10, Issue 11, 2008, Pages 1143-1148

  Arya, Arash ^a   Block, Michael ^b   Kautzner, Josef ^c   Lewalter, Thorsten ^d   Mörtel, Heinrich ^e   Sack, Stefan ^f   Schumacher, Burghard ^g   Søgaard, Peter ^h   Taborsky, Milos ⁱ   Husser, Daniela ^a   Hindricks, Gerhard ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b Klinik Augustinum Munchen   (Germany)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e Study Center Erlangen   (Germany)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

^g Herz und Gefäßklinikum Bad Neustadt GmbH   (Germany)

^h GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

ⁱ NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Early detection; Heart failure; Home monitoring; IN TIME study; Patient management

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FOLLOW UP; HEALTH STATUS; HEART FAILURE; HOME MONITORING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; TIME SERIES ANALYSIS;

CAUSE OF DEATH; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEART FAILURE; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; MONITORING, PHYSIOLOGIC; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 53949110779     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.08.004     Document Type: Article

References (20)

1. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
2. Domanski M.J., Krause-Steinrauf H., Massie B.M., et al. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail 9 (2003) 354-363
3. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005 Jan 20) 225-237
4. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
5. Solomon S.D., Dobson J., Pocock S., et al. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure. Circulation 116 (2007) 1482-1487
6. Opasich C., Rapezzi C., Lucci D., et al. Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF Registry). Am J Cardiol 88 (2001) 382-387
7. Madsen B.K., Rasmussen V., and Hansen J.F. Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography. Int J Cardiol 58 (1997) 151-162
8. Lechat P., Hulot J.S., Escolano S., et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 103 (2001) 1428-1433
9. Moore R.K., Groves D.G., Barlow P.E., et al. Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure. Eur J Heart Fail 8 (2006) 585-590
10. Adamson P.B., Smith A.L., Abraham W.T., et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 110 (2004) 2389-2394
11. Louis A.A., Turner T., Gretton M., Baksh A., and Cleland J.G. A systematic review of telemonitoring for the management of heart failure. Eur J Heart Fail 5 (2003) 583-590
12. Cleland J.G., Louis A.A., Rigby A.S., Janssens U., and Balk A.H. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 45 (2005) 1654-1664
13. Goldberg L.R., Piette J.D., Walsh M.N., et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J 146 (2003) 705-712
14. Pinna G.D., Maestri R., Andrews D., et al. Home telemonitoring of vital signs and cardiorespiratory signals in heart failure patients: system architecture and feasibility of the HHH model. Int J Cardiol 120 (2007) 371-379
15. Jaarsma T., van der Wal M.H., Lesman-Leegte I., et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 168 (2008) 316-324
16. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 7 (2001) 176-182
17. Yu C.M., Abraham W.T., Bax J., et al. Predictors of response to cardiac resynchronization therapy (PROSPECT)-study design. Am Heart J 149 (2005) 600-605
18. Linde C., Gold M., Abraham W.T., and Daubert J.C. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure-the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J 151 (2006) 288-294
19. Pfeffer M.A., Swedberg K., Granger C.B., et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362 (2003) 759-766
20. O'Meara E., Solomon S., McMurray J., et al. Effect of candesartan on New York Heart Association functional class. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J 25 (2004) 1920-1926